(Q42937533)

English

Randomized, double-blind, placebo-controlled, dose-escalating phase I, healthy subjects study of intravenous OPN-305, a humanized anti-TLR2 antibody

scientific article published on 23 July 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 November 2017

Randomized, double-blind, placebo-controlled, dose-escalating phase I, healthy subjects study of intravenous OPN-305, a humanized anti-TLR2 antibody (English)

1 reference

Europe PubMed Central

11 November 2017

toll-like receptor

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

M Reilly

1

1 reference

Europe PubMed Central

11 November 2017

R M Miller

2

1 reference

Europe PubMed Central

11 November 2017

M H Thomson

3

1 reference

Europe PubMed Central

11 November 2017

V Patris

4

1 reference

Europe PubMed Central

11 November 2017

P Ryle

5

1 reference

Europe PubMed Central

11 November 2017

L McLoughlin

6

1 reference

Europe PubMed Central

11 November 2017

P Mutch

7

1 reference

Europe PubMed Central

11 November 2017

P Gilboy

8

1 reference

Europe PubMed Central

11 November 2017

C Miller

9

1 reference

Europe PubMed Central

11 November 2017

M Broekema

10

1 reference

Europe PubMed Central

11 November 2017

B Keogh

11

1 reference

Europe PubMed Central

11 November 2017

W McCormack

12

1 reference

Europe PubMed Central

11 November 2017

J van de Wetering de Rooij

13

1 reference

Europe PubMed Central

11 November 2017

language of work or name

0 references

publication date

23 July 2013

1 reference

Europe PubMed Central

11 November 2017

Clinical Pharmacology & Therapeutics

1 reference

Europe PubMed Central

11 November 2017

94

1 reference

Europe PubMed Central

11 November 2017

593-600

1 reference

Europe PubMed Central

11 November 2017

5

1 reference

Europe PubMed Central

11 November 2017

Machine perfusion versus cold storage for the preservation of kidneys donated after cardiac death: a multicenter, randomized, controlled trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3805945

27 May 2018

TLR2 and TLR4 in ischemia reperfusion injury

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3805945

27 May 2018

Formulation and delivery issues for monoclonal antibody therapeutics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3805945

27 May 2018

Cyclosporine-induced renal injury induces toll-like receptor and maturation of dendritic cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3805945

27 May 2018

Signaling danger: toll-like receptors and their potential roles in kidney disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3805945

27 May 2018

Cell death induced by acute renal injury: a perspective on the contributions of apoptosis and necrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3805945

27 May 2018

Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3805945

27 May 2018

An essential role of the NF-kappa B/Toll-like receptor pathway in induction of inflammatory and tissue-repair gene expression by necrotic cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3805945

27 May 2018

A randomized trial of basiliximab with three different patterns of cyclosporin A initiation in renal transplant from expanded criteria donors and at high risk of delayed graft function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3805945

16 August 2018

TNF-alpha-dependent bilateral renal injury is induced by unilateral renal ischemia-reperfusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/23880971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo expression of Toll-like receptor 2 and 4 by renal epithelial cells: IFN-gamma and TNF-alpha mediated up-regulation during inflammation

1 reference

https://pubmed.ncbi.nlm.nih.gov/23880971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment with OPN-305, a humanized anti-Toll-Like receptor-2 antibody, reduces myocardial ischemia/reperfusion injury in pigs

1 reference

https://pubmed.ncbi.nlm.nih.gov/23880971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of TLR2 promotes graft function in a murine model of renal transplant ischemia-reperfusion injury

1 reference

https://pubmed.ncbi.nlm.nih.gov/23880971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/CLPT.2013.150

1 reference

Europe PubMed Central

11 November 2017

1 reference

Europe PubMed Central

11 November 2017

1 reference

Europe PubMed Central

11 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42937533&oldid=1974071779"